Related references
Note: Only part of the references are listed.Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease
T. Dassopoulos et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Long-term Outcome of Patients With Crohn's Disease Who Respond to Azathioprine
Marine Camus et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Incidence of inflammatory bowel disease in the province of Styria, Austria, from 1997 to 2007: A population-based study
W. Petritsch et al.
JOURNAL OF CROHNS & COLITIS (2013)
Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease
L. Chouchana et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease
Millie D. Long et al.
GASTROENTEROLOGY (2012)
Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease
Harry Sokol et al.
INFLAMMATORY BOWEL DISEASES (2012)
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Luke Jostins et al.
NATURE (2012)
Who Wants to Take a Thiopurine Holiday?
Peter D. R. Higgins
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Relapse Rate Following Azathioprine Withdrawal in Maintaining Remission for Crohn's Disease: A Meta-Analysis
Helen French et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
Laurent Peyrin-Biroulet et al.
GASTROENTEROLOGY (2011)
Epidemiology and Natural History of Inflammatory Bowel Diseases
Jacques Cosnes et al.
GASTROENTEROLOGY (2011)
Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease
M. A. Smith et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial
Walter Reinisch et al.
GUT (2010)
Current Smoking, Not Duration of Remission, Delays Crohn's Disease Relapse Following Azathioprine Withdrawal
Harry Sokol et al.
INFLAMMATORY BOWEL DISEASES (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
Gert Van Assche et al.
JOURNAL OF CROHNS & COLITIS (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2010)
Review: Immunomodulators for all patients with inflammatory bowel disease?
Sandro Ardizzone et al.
Therapeutic Advances in Gastroenterology (2010)
Azathioprine and 6-Mercaptopurine for the Prevention of Postoperative Recurrence in Crohn's Disease: A Meta-Analysis
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse
Xavier Treton et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie et al.
LANCET (2009)
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
Eliza Prefontaine et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)
Risk factors for opportunistic infections in patients with inflammatory bowel disease
Murat Toruner et al.
GASTROENTEROLOGY (2008)
The long-term efficacy of azathioprine does not wane after four years of continuous treatment in patients with steroid-dependent luminal Crohn's disease
Gerassimos J. Mantzaris et al.
JOURNAL OF CROHNS & COLITIS (2007)
Long-term effectiveness of azathioprine in IBD beyond 4 years:: A European multicenter study in 1176 patients
Martin H. Holtmann et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
A randomized, douuble-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine
M Lémann et al.
GASTROENTEROLOGY (2005)
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease
P Rutgeerts et al.
GASTROENTEROLOGY (2004)
Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease:: increased relapse rate the following year
M Vilien et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review
AG Fraser et al.
GUT (2002)
Azathioprine for maintenance of remission in Crohn's disease: Benefits outweigh the risk of lymphoma
JD Lewis et al.
GASTROENTEROLOGY (2000)
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
MC Dubinsky et al.
GASTROENTEROLOGY (2000)
Share Paper
